With Australia’s largest population, strongest economy, and innovative life sciences sector, New South Wales (NSW) is home to an integrated, world-class health and medical research sector that is solving some of the world’s most complex and burdensome healthcare challenges.
NSW has Australia’s largest and best-performing public healthcare system, and a globally significant research and development ecosystem with strong government backing. World-leading public healthcare is delivered through 228 public hospitals that are managed by 15 local health districts and two specialty networks, all supported by centralised policy and support pillars.
The NSW Government has invested A$10.8 billion over four years for research and development. Continuous financial investment ensures that internationally recognised research is translated into therapies and practice both locally and globally.
NSW is a premier destination for high-quality, efficient, and cost-effective clinical trials, particularly in early-phase. Trials in NSW are 28 percent less expensive than in the US, increasing to up to 60 percent with federal R&D tax incentives.
NSW has Australia’s largest and best-performing public healthcare system, and a globally significant research and development ecosystem with strong government backing. World-leading public healthcare is delivered through 228 public hospitals that are managed by 15 local health districts and two specialty networks, all supported by centralised policy and support pillars.
The NSW Government has invested A$10.8 billion over four years for research and development. Continuous financial investment ensures that internationally recognised research is translated into therapies and practice both locally and globally.
NSW is a premier destination for high-quality, efficient, and cost-effective clinical trials, particularly in early-phase. Trials in NSW are 28 percent less expensive than in the US, increasing to up to 60 percent with federal R&D tax incentives.
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
